Healthcare Industry News: Systagenix
News Release - November 21, 2013
KCI Introduces the Next Generation V.A.C.Via(TM) Therapy SystemPortable System Provides Enhanced Features for Patients
SAN ANTONIO--(Healthcare Sales & Marketing Network)--Kinetic Concepts, Inc. (KCI) today announced that the next generation V.A.C.Via™ Negative Pressure Wound Therapy System has received FDA clearance. The V.A.C.Via™ Therapy System is a single patient use, ultra-portable V.A.C.® Therapy System that provides simplified wound care for patients with moderate- to low-exudating wounds. It features a diaphragm pump for faster draw down, longer battery life and higher leak rate threshold than the original device. These enhancements make the system both effective and convenient for patients.
In addition to providing all the benefits of V.A.C.® Therapy, V.A.C.Via™ Therapy patients can enjoy V.A.C.® Therapy with a discreet, portable device; clinicians can benefit from the convenience of having easy access to an off-the-shelf, single-patient-use device; and hospitals will appreciate the potential cost savings of reduced length of stay.
“We’ve listened to the feedback from our customers and patients and have taken our original system and enhanced it to better meet their needs,” said Jim Cunniff, senior vice president, Americas, KCI. “The V.A.C.Via™ Therapy Unit is designed to help patients return to their normal lifestyle, while receiving up to seven days of negative pressure wound therapy in a compact, portable unit.”
The V.A.C.Via™ Therapy System can be used in the acute setting for patients transitioning home and who are in need of continued V.A.C.® Therapy. The product will be available in the US in early December.
For more information on KCI and the next generation V.A.C.Via™ Therapy System, please visit www.KCI1.com.
Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 65 countries around the world. KCI, along with LifeCell Corporation and Systagenix Wound Management, form one globally diversified wound care, biologics and regenerative medicine company, committed to advancing the science of medicine to reduce complications, speed healing and improve patient lives. Headquartered in San Antonio, Texas, the company is a leader in the medical technology industry with the most comprehensive offering of best-in-class surgical and chronic wound therapies. Additional information about KCI and its products is available at www.KCI1.com.
Source: Kinetic Concepts
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.